Study Stopped
Dr. Bello is no longer a PI at the institution. Data analysis was not completed.
Potential Restoration of the Infant Microbiome
PRIME
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Understanding the microbiome's important role in human health, the investigators wish to determine how the development of the infant microbiome is impacted by delivery mode, comparing natural vaginal birth to scheduled C-sections. Investigators will look at the oral, nasal, skin, vaginal and fecal bacteria of 78 mothers and their infants from birth to age 1.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 5, 2015
CompletedStudy Start
First participant enrolled
April 1, 2015
CompletedFirst Posted
Study publicly available on registry
April 2, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedJanuary 12, 2018
January 1, 2018
2.8 years
March 5, 2015
January 10, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bacterial diversity of several body sites on mother and baby throughout one year post-birth as measured by the number and type of different bacteria present
Investigators will first use Illumina to obtain sequences of the bacterial mitochondrial DNA from collected samples. QIIME, LEfSe, and other bioinformatic tools will then be used to calculate the bacterial diversity (richness, relative abundances) in each sample, as well as compare bacterial communities (beta diversity), sourcetracking to determine origin from maternal sites, random forest to classify communities, and other tools to describe the dynamics of the infant microbiome.
Day of Birth; Days 1 and 3; Weeks 1, 2, 3 and 4; Months 2, 3, 4, 5, 6, 7, 8, 9, 10, 11; Year 1
Study Arms (3)
Scheduled C-section
NO INTERVENTIONBabies that are scheduled to be born in a hospital via standard C-section procedure.
Vaginal Delivery
NO INTERVENTIONBabies that are born via vaginal delivery, either at home, at a birthing center or hospital. Drugs may be administered during labor.
Scheduled C-section with Exposure
EXPERIMENTALBabies that are scheduled to be born in a hospital via standard C-section procedure, as well as are swabbed with gauze containing their mother's vaginal microbiota just after delivery. The intervention: Newborn exposure to mother vaginal microbiota.
Interventions
Babies are swabbed just after delivery with gauze containing their mother's vaginal microbiota.
Eligibility Criteria
You may qualify if:
- Healthy mothers, 18-40 years old with uncomplicated pregnancies delivering at term (37 weeks or later)
- Mothers of any ethnic or social background that can speak, read, and understand English to the extent that they can consent in English OR mothers who do not speak English yet agree to come to an NYU hospital for all sampling.
- Scheduled C-section
- Vaginal pH ≤ 4 at the time of birth (as measured via pH paper)
You may not qualify if:
- Mothers with pre-eclampsia or other serious chronic conditions
- Mothers with complicated pregnancies
- Mothers under 18 years of age or over 40 years of age
- Babies with complications during delivery
- Babies delivered prior to 37 weeks of gestation
- Mothers reported positive to active primary herpes, genital warts, HIV, Group B Streptococcus, gonorrhea, chlamydia, bacterial vaginosis, yeast infection, or trichomoniasis.
- Mothers with vaginal pH \> 4 at the time of birth (as measured via pH paper).
- Known positive Group B Strep test results by rectal vaginal swab within five weeks of the scheduled caesarian.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unknown Facility
New York, New York, 10010, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Maria Gloria Dominguez-Bello, PhD
NYU School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 5, 2015
First Posted
April 2, 2015
Study Start
April 1, 2015
Primary Completion
January 1, 2018
Study Completion
January 1, 2018
Last Updated
January 12, 2018
Record last verified: 2018-01